David Bailie, M.D., the founder and president of the Arizona Institute of Sports, Knees and Shoulders has accepted the position of chief medical officer and chairman of the surgeon advisory board of Integrated Endoscopy, Inc. of Rancho Santa Margarita, California.
Bailie brings more than 27 years of experience in orthopedic surgery to the task. A recognized researcher, speaker and clinician, Bailie has contributed to the development of numerous orthopedic implants and devices for leading medical companies. He has also served as team physician for professional sports teams including the NBA, NFL, NBA the PGA Tour, Major and Minor League Baseball organizations and the U.S. Olympic Women’s Gymnastics Team.
David Bailie to Head Surgeon Advisory Board of Integrated Endoscopy
1 min read Premium comments
Bailie is the author of more than 30 clinical articles and lectures at conferences, hospitals and schools.
“We are pleased that David Bailie is joining Integrated Endoscopy’s team of established and accomplished business and clinical leaders,” said Brad Sharp, CEO of Integrated Endoscopy. “Dr. Bailie’s extraordinary medical expertise and leadership will be invaluable as we work to educate the marketplace about our next-generation single-use arthroscope portfolio and other advanced technologies that will lead to a paradigm shift in the way ORs operate.”
“I am honored to be involved with such an esteemed group of engineers, experienced business executives, and committed investors,” Bailie said. “Integrated Endoscopy’s fresh vision and patented technology will enhance the way surgeons perform all types of endoscopic surgery. The ability of this technology to decrease costs, improve efficiency, and enhance the safety of surgical procedures is significant.”
Integrated Endoscopy, Inc., designs, manufactures, and markets a new generation of medical devices serving the arthroscopic surgery market. Its flagship product Nuvis is an FDA-cleared single-use arthroscope that delivers high-definition image quality for a fraction of the cost of reusable endoscopes.
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.